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About NHMRC 
NHMRC is Australia’s peak body for supporting health and medical research by funding the 
best research selected through a competitive peer review process.  NHMRC also develops 
health advice for the Australian community, health professionals and governments in the 
form of public health and clinical practice guidelines, Public Statements, Information Papers 
and evidence reviews.  NHMRC also provides advice on ethical behaviour in health care and 
in the conduct of health and medical research. 
The work of NHMRC is guided by its Strategic Plan, and defined by the National Health and 
Medical Research Council Act (1992).  The Strategic Plan covers a three year period and is 
submitted to the Health Minster for approval, prior to being tabled in Parliament. The 
NHMRC Strategic Plan 2013-2015 has identified ‘claiming benefit for human health not 
based on evidence’ as a major health issue for consideration. 
Within our health system, there are practices which are currently not based on sturdy 
evidence.  Health and medical research is the means by which we test the value of 
procedures, processes, systems and products offered to patients, or proposed as preventive 
means by the health system and its policy and decision makers.  NHMRC is a strong 
advocate for the development and use of evidence to inform policy and practice and in recent 
years, NHMRC and other health research funding bodies have increased funding for such 
research. 
This draft Information Paper is an example of NHMRC’s function to “advise the community” 
under section 7(1)(a) of the NHMRC Act 1992. Published research on a topic of interest has 
been identified, analysed and synthesised into a summary of the evidence for the Australian 
community, health professionals and policy makers.  This information can then be utilised to 
assist people in making healthcare choices, guide clinical practice or influence policy and 
perhaps new funding approaches, all of which lead to improvements in health and health care 
delivery. 
NHMRC is of the view that when offering treatments for illness, all health practitioners must 
give consideration to the evidence for the effectiveness of such treatments. This consideration 
should be reflected in their professional ethics and clinical practices.  
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Introduction 
Purpose 
This information paper provides an overview of evidence
*
 from research on the effectiveness 
of homeopathy in treating health conditions in humans. 
It summarises the findings of an assessment of homeopathy undertaken by National Health 
and Medical Research Council (NHMRC), which included an overview of published 
systematic reviews,(1) evaluation of information provided by homeopathy interest groups and 
the public,(2) and consideration of clinical practice guidelines and government reports on 
homeopathy published in other countries. 
Scope 
NHMRC assessed the evidence on homeopathy to answer this question: Is homeopathy an 
effective treatment for health conditions, compared with no homeopathy, or compared to 
other treatments?  
NHMRC did not consider evidence for whether or not homeopathy is effective for preventing 
health conditions (including evidence about homeopathic ‘vaccines’), or whether homeopathy 
is good for general health.  
NHMRC did not assess evidence on the safety of the ingredients of homeopathic medicines. 
What is homeopathy? 
Homeopathy is a type of complementary and alternative medicine. It is based on the principle 
that ‘like cures like’ – the belief that substances that may cause illness or symptoms in a 
healthy person can, in very small doses, treat those symptoms in a person who is unwell. 
Homeopathy is also based on the belief that molecules in highly diluted substances retain a 
‘memory’ of the original substance. Specifically, homeopathic remedies are repeatedly 
diluted and agitated in a process known as ‘potentisation’ or ‘dynamisation’.  
Homeopathic medicines are prepared by taking a substance (e.g. plants, animal material, or 
chemical), diluting it in water or alcohol, then forcefully hitting the container against a hand 
or a surface. This process is repeated several times. Homeopathic medicines can include 
pellets placed under the tongue, tablets, liquids, ointments, sprays and creams. 
Homeopaths mostly provide ‘individualised homeopathy’. This means that the homeopath 
matches all the person’s symptoms to a single homeopathic medicine, rather than treating the 
person for a particular health condition using one or more homeopathic medicines. Some 
homeopaths provide ‘clinical homeopathy’. This means that the homeopath chooses one or 
more homeopathic medicines to treat a particular health condition.  
                                                 
*
 In this information paper, evidence is defined as health research in humans using internationally accepted 
methods (e.g. properly designed research studies). It does not include individual experiences, testimonials or 
case reports, or research that was not done using standard methods. 
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Why did NHMRC conduct an assessment of homeopathy? 
NHMRC is responsible for providing Australians with reliable advice and the best available 
evidence to help people make informed health decisions. This includes decisions about using 
complementary and alternative medicines. 
NHMRC is concerned that unconventional products and procedures are often promoted to 
improve people’s health when there is little or no evidence of their benefit, except for the 
benefits people experience when they believe that a treatment is effective (the placebo 
effect).(3, 4) Sometimes patients may be misled into rejecting practices and treatments that 
are proven to be effective. 
NHMRC is supporting research on complementary and alternative medicines and therapies,
†
 
and is helping health professionals and patients to find reliable information about these 
treatments.(3, 4) 
Homeopathy is commonly used around the world and in Australia. A 2009 World Health 
Organisation review on the safety of Homeopathy estimated that each year, Australians spend 
an estimated US $7.3 million on homeopathic medicines.(5) Some homeopathic medicines 
are listed on the Australian Register of Therapeutic Goods.
‡
 However, people disagree about 
whether or not homeopathy is effective.  
People who use homeopathy need to understand the potential benefits and risks. Health 
professionals also need to know what homeopathy is, be aware of the current scientific 
evidence from research on homeopathy, and understand any possible benefits and risks to 
patients – particularly when people decide to use homeopathy instead of other treatments, 
especially in place of other, evidence based treatments. 
There have already been several reviews and reports on the effectiveness of homeopathy. 
However, reports on homeopathy commissioned by foreign governments have reached 
different conclusions.(6, 7) 
NHMRC undertook an assessment of the evidence, to provide Australians with reliable 
information on this topic. 
                                                 
†
 Since 2000, NHMRC has provided more than $86 million in funding for scientific research into 
complementary medicine and alternative therapies. [Source: http://www.nhmrc.gov.au/your-
health/complementary-and-alternative-medicines 
‡
 Medicines listed on the Australian Register of Therapeutic Goods are labelled with an Australian listing 
(AUST L) number. An AUST L number issued by the Therapeutic Goods Administration  indicates that the 
product’s ingredients have been assessed for quality and safety and have a low risk of poisoning or major side 
effects. However, the TGA does not assess the effectiveness of these products. For more information, visit the 
Therapeutic Goods Administration’s website (http://www.tga.gov.au/consumers/information-medicines-
label.htm).  
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About the NHMRC assessment of the evidence 
NHMRC’s approach to assessing health evidence  
When assessing the effectiveness of treatments for health conditions, not all evidence has 
equal value.  
It is not possible to tell whether a health treatment is effective or not simply by considering 
individuals’ experiences or healthcare practitioners’ beliefs. One reason that personal 
testimonials are not reliable is that people experience health benefits when they believe that a 
treatment is effective (the placebo effect). Another is that healthcare practitioners cannot 
always tell whether changes in a person’s health condition are due to the treatment or some 
other reason.  
Research studies
§
 provide more information, but some types of studies provide stronger 
evidence than others because of how they are designed. Reliable information about whether a 
particular medicine is effective for treating a health condition comes from studies in which: 
 the medicine is compared with a substance that has no effect (placebo) in a group of 
people with the health condition (placebo-controlled trial), or the medicine is compared 
with an effective standard treatment (controlled trial) 
 each participant is given either the medicine or the placebo/other treatment at random 
(randomised trial) 
 participants and researchers do not know whether they are taking the medicine or the 
placebo/other treatment until the study is finished (double-blinded trial) 
 there are enough participants to be reasonably confident that, if there is a bigger change in 
the health condition in one group, this is not just due to chance 
 the correct statistical methods are used to analyse the results. 
The results of individual studies need to be repeated in other independent studies, to make 
sure the effects seen were not just due to chance. The most reliable information comes from 
research that combines the results of all available similar studies and analyses the results 
together (systematic reviews). 
When reviewing health evidence and drafting health advice, NHMRC uses a rigorous 
approach developed by Australian experts in research methods.(8) In the NHMRC system for 
evaluating health evidence there are different levels of evidence, ranging from level one 
(highest level, strongest evidence) to level four (lowest level, weakest evidence).(8) NHMRC 
considers the level of each study, to decide how much that study’s results should be relied on 
when judging the overall evidence. 
A treatment is considered effective for treating a health condition if it meets all of these key 
criteria: 
 The treatment causes health improvements that cannot be explained by the placebo effect 
 Health improvements that occur in people taking the treatment are unlikely to be due to 
chance 
                                                 
§
 In this information paper, a research study means a planned, structured scientific research project designed to 
see whether a treatment is effective in humans (e.g. a trial). 
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 The health improvements caused by the treatment are meaningful for a person’s overall 
health 
 The health improvement occurs consistently in several studies. 
How did NHMRC find evidence about homeopathy? 
NHMRC used a combination of three main sources of information about the effectiveness of 
homeopathy (Figure 1): 
 published systematic reviews (summarised in the overview report)(1)  
 information provided by homeopathy interest groups and the public (summarised in the 
review of submitted literature)(2)  
 clinical practice guidelines and government reports on homeopathy published in other 
countries. 
The NHMRC’s assessment was guided by a committee of experts appointed in 2012 (see 
The Homeopathy Working Committee). 
Overview of systematic reviews 
Many systematic reviews of homeopathy studies have already been published. NHMRC 
commissioned a professional research group (Optum) to do a thorough search of published 
research to identify systematic reviews of studies that compared homeopathy with no 
homeopathy, or with other treatments, and measured effectiveness in patients with any health 
condition. 
The search was designed to find systematic reviews that included prospective, controlled 
studies.
**
 The researchers searched databases of health publications to find reports of 
systematic reviews published in English between January 1997 and 3 January 2013. 
For each health condition, the research group collated the findings of the systematic reviews 
and assessed the quality and reliability of the evidence. The findings are described in detail in 
the overview report.(1)  
Literature provided by homeopathy interest groups and individuals 
NHMRC considered published articles on the effectiveness of homeopathy provided by the 
Australian Homoeopathy Association and the Australian Medical Fellowship of Homeopathy. 
NHMRC also considered articles submitted by members of the public. Evidence was only 
considered if it had been provided to NHMRC before the NHMRC’s assessment process 
began. 
All articles received were assessed by a professional research group (Optum) to identify 
evidence within the scope of NHMRC’s assessment. Only the types of evidence that were 
included in the overview (prospective, controlled studies) were assessed in detail. For each 
study included, the researchers assessed its quality and the reliability of its results, and 
summarised the findings in the review of submitted literature.(2)  
                                                 
**
 ‘Prospective’ design means the health outcomes to be measured were defined in advance, the way to measure 
the effects of treatment on these outcomes was planned in advance, and the results were then measured at 
specified times. ‘Controlled’ means homeopathy was compared with either placebo or another treatment in 
similar groups of people with the health condition. 
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NHMRC and the Homeopathy Working Committee considered this evidence when preparing 
this information paper. 
Evidence-based guidelines and government reports 
NHMRC looked for major reports by other government bodies. Two recent major 
government reports were identified: 
 House of Commons Science and Technology Committee. Evidence check 2: 
Homeopathy. London: The Stationery Office; 2010. 
 Bornhöft G, Matthiessen P, editors. Homeopathy in healthcare – Effectiveness, 
appropriateness, safety, costs. Berlin: Springer; 2012. 
NHMRC also found several evidence-based clinical practice guidelines that included 
recommendations about the use of homeopathy in the treatment of various health 
conditions.(9-14). All were published or funded by the UK National Institute for Health and 
Clinical Excellence.  
The Homeopathy Working Committee considered these reports and clinical practice 
guidelines when developing this information paper. 
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Figure 1. Components of NHMRC’s assessment of homeopathy 
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overview of the evidence. NHMRC also compiled a dossier of evidence-based clinical practice 
guidelines on homeopathy and reports on the effectiveness of homeopathy commissioned by other 
governments, for the Homeopathy Working Committee to consider.   
EVIDENCE ASSESSMENT 
 Overview report 
 Review of submitted literature 
 Other government reports and 
guidelines 
Homeopathy Working Committee consideration 
DRAFT INFORMATION PAPER 
 Summarises the assessment of the 
evidence in non-technical language 
 Provides advice for the general 
community about the evidence on the 
effectiveness of homeopathy 
Independent 
methodological 
review of 
Overview 
report 
Independent 
expert review 
 
Public 
consultation 
submissions 
NHMRC Council consideration 
Final Information Paper NHMRC Position Statement 
Homeopathy Working Committee  
 Final Information Paper 
 Report on how submissions were 
considered  
NHMRC DRAFT INFORMATION PAPER [APRIL 2014] 
Draft for public consultation  9 
How did NHMRC assess the evidence about homeopathy? 
NHMRC used standardised, accepted methods for assessing the quality and reliability of 
evidence for whether or not a therapy is effective for treating health conditions (see 
NHMRC’s approach to assessing health evidence). 
The overview considered only evidence from systematic reviews that included prospectively 
designed and controlled studies conducted in humans (including randomised controlled trials, 
pseudo-randomised controlled trials, non-randomised controlled trials and prospective cohort 
studies). 
For each health condition, the overview of systematic reviews assessed:(1)  
 the number of systematic reviews that reported evidence on that health condition 
 the quality of the systematic reviews, using a standard, internationally accepted method†† 
 the number and type of research studies that were included in the systematic reviews 
 the quality of each study and its number of participants, as reported in the systematic 
reviews 
 the overall level of confidence in the body of evidence for the use of homeopathy for that 
health condition, ranging from ‘very low’ to ‘high’.‡‡ 
The methods are described in the overview report.(1)  
For each health condition, the Homeopathy Working Committee summarised the body of 
evidence in a statement, using standard wording and applying the same considerations 
consistently (see Findings of the NHMRC overview). 
When assessing the extra information provided by homeopathy interest groups and the public 
(a total of 343 articles), a similar method of assessment was applied: only prospectively 
designed and controlled studies conducted in humans (including randomised controlled trials, 
pseudo-randomised controlled trials, non-randomised controlled trials and prospective cohort 
studies) were considered.  
Articles that had already been identified in the overview of systematic reviews and included 
in the overview report were not considered again. For the remaining prospectively designed 
and controlled studies that had not already been included in a systematic review, the 
researchers evaluated the quality of each study using a standardised internationally accepted 
method.
§§
  
                                                 
††
 Systematic reviews were assessed using the Assessing the Methodological Quality of Systematic Reviews 
(AMSTAR) method (Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool 
to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007; 7: 10.). 
‡‡
 The level of confidence in the body of evidence was recorded as ‘very low’ if any estimate of effect was 
uncertain (i.e. overall, the quality of the available information was not good enough to be able to estimate the 
true effect of homeopathy on that health condition). The level of confidence in the body of evidence was 
recorded as ‘high’ when further research was very unlikely to change confidence in the estimate of effect (i.e. 
the available evidence was high quality and the effect of homeopathy in that health condition was clear). 
§§
 The quality of studies was assessed using the quality appraisal methodology checklists developed by the 
Scottish Intercollegiate Guidelines Network (Scottish Intercollegiate Guidelines Network. SIGN 50: a guideline 
developer’s handbook (2011). Available at: http://www.sign.ac.uk/guidelines/fulltext/50/index.html) 
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The methods are described in the review of submitted literature.(2)  
What quality checks were applied to NHMRC’s assessment of the 
evidence on homeopathy? 
NHMRC commissioned an independent organisation with expertise in research methodology 
(The Australasian Cochrane Centre) to review the methods used in the overview and ensure 
that processes for identifying and assessing the evidence were scientifically rigorous, 
consistently applied, and clearly documented. Optum considered all the reviewer’s comments 
and suggestions in consultation with the Homeopathy Working Committee, and amended the 
report accordingly. 
[NHMRC has invited experts in evidence based medicine, clinical trials, and complementary 
medicines research to review this information paper, at the same time as the current public 
consultation process. All comments received will be collated and considered by the 
Homeopathy Working Committee.] 
Summary of evidence 
Overall finding 
NHMRC concludes that the assessment of the evidence from research in humans does not 
show that homeopathy is effective for treating the range of health conditions considered. 
There were no health conditions for which there was reliable evidence that homeopathy was 
effective. No good-quality, well-designed studies with enough participants for a meaningful 
result reported either that homeopathy caused greater health improvements than a substance 
with no effect on the health condition (placebo), or that homeopathy caused health 
improvements equal to those of another treatment. 
 For some health conditions, homeopathy was found to be not more effective than placebo. 
 For other health conditions, some studies reported that homeopathy was more effective 
than placebo, or as effective as another treatment, but those studies were not reliable.  
 For the remaining health conditions it was not possible to make any conclusion about 
whether homeopathy was effective or not, because there was not enough evidence.  
To be confident that the health benefits of homeopathy that were reported in some studies 
were not just due to chance or the placebo effect, they would need to be confirmed by other 
large, well-designed studies. 
Evidence included in the overview 
The overview considered 57 systematic reviews that assessed the effectiveness of 
homeopathy for treating health conditions.(1) 
The systematic reviews searched for published research on homeopathy for 68 health 
conditions, and found published research on 61 of these conditions. No published research 
was found for the remaining 7 conditions.(1) 
NHMRC took a range of factors into account when considering the evidence in the 
systematic reviews: 
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 whether it was relevant to the question of whether or not homeopathy is effective for 
treating health conditions 
 the type of studies and whether they were well designed 
 whether the reports included enough information to judge whether the studies were done 
well and whether the results were likely to be reliable or unreliable 
 whether studies included enough participants to provide meaningful results 
 whether studies compared homeopathy with placebo or with another treatment.  
The overview considered only studies with these features:
***
 
 The health outcomes to be measured were defined in advance, the way to measure the 
effects of treatment on these outcomes was planned in advance, and the results were then 
measured at specified times (prospectively designed studies).  
 The study compared a group of people who were given homeopathic treatment with a 
similar group of people who were not given homeopathic treatment (controlled studies). 
NHMRC did not consider observational studies, individual experiences and testimonials, case 
series and reports, or research that was not done using standard methods. 
For each health condition, all the available evidence was grouped together to form a body of 
evidence on that condition. A body of evidence was considered more reliable if it included 
studies that were high quality, well designed and with enough participants to make its results 
meaningful. A body of evidence was considered less reliable if there were very few studies, 
or if the studies were poor quality, badly designed, or included too few participants. 
For more information on NHMRC’s processes for reviewing evidence, see About the 
NHMRC assessment of homeopathy. 
Findings of the NHMRC overview 
The quality of the evidence was generally low, so it was not possible to be confident that the 
evidence was reliable.(1) 
Based on all the evidence considered, there were no health conditions for which there was 
reliable evidence that homeopathy was effective. No good-quality, well-designed studies with 
enough participants for a meaningful result reported either that homeopathy caused greater 
health improvements than placebo, or caused health improvements equal to those of another 
treatment.(1) 
Table 1 summarises the evidence. 
Homeopathy compared with placebo 
Research studies that compare a medicine with placebo are designed to test whether the 
medicine is effective as a treatment for the health condition. The systematic reviews 
                                                 
***
 The following types of studies were considered if included in systematic reviews: randomised controlled 
trials, pseudo-randomised controlled trials, non-randomised controlled trials and prospective cohort studies. 
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identified research studies that compared homeopathy with placebo for 55 health 
conditions.
†††
 
For 13 health conditions, homeopathy was reported to be not more effective than placebo in 
either: 
 all the studies found (regardless of size and quality), or  
 a large majority of those studies that were reliable (good-quality, well designed and with 
enough participants for a meaningful result).(1) 
For 14 health conditions, some studies reported that homeopathy was more effective than 
placebo, but these studies were not reliable. They were not good quality (well designed and 
well done), or they had too few participants, or both.(1) To be confident that the reported 
health benefits were not just due to chance or the placebo effect, they would need to be 
confirmed by other large, well-designed studies.(1) 
For 29 health conditions, only one study that compared homeopathy with placebo was found, 
and each of these studies was unreliable. They were either poor quality (poorly designed or 
poorly done) or unknown quality, or they had too few participants, or both.(1) For these 
conditions, it was not possible to make any conclusion about whether homeopathy was 
effective or not.  
Homeopathy compared with other treatments 
Research studies that compare a medicine with another treatment are designed to test whether 
the medicine is as effective as (or more effective than) existing treatment options. This type 
of study is normally used when previous studies have already shown that the test medicine is 
more effective than placebo. The systematic reviews identified research studies that 
compared homeopathy with at least one other treatment for 15 conditions (these included 10 
health conditions for which there were also studies that compared homeopathy with placebo). 
Comparative studies can only provide useful information if the comparator treatment is 
already known to be effective. Some studies that compare two treatments also include a 
group of people who receive placebo, to make sure health effects in the groups taking the test 
medicine or the comparator treatment are not just due to the placebo effect.  
In some studies considered in NHMRC’s assessment, homeopathy was compared with 
treatments that were not standard treatments for the condition.(1) In those studies, it was not 
possible to judge the true effect of homeopathy on the health condition. 
For 8 health conditions, some studies reported that homeopathy was as effective as another 
treatment, or more effective than another treatment, but these studies were not reliable. They 
were not good quality (well designed and well done), or they had too few participants, or 
both.(1) To be confident that the reported health benefits were not just due to chance or the 
placebo effect, they would need to be confirmed by other large, well-designed studies. 
For 7 health conditions, only one study that compared homeopathy with another treatment 
was found, and each of these studies was unreliable. They were either poor quality (poorly 
designed or poorly done) or unknown quality, or they had too few participants, or both.(1) 
                                                 
†††
 These included one condition (diarrhoea in children) for which studies of a combined homeopathy tablet 
(clinical homeopathy) and studies of individualised homeopathy were analysed separately by NHMRC. 
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For these conditions, it was not possible to make any conclusion about whether homeopathy 
was effective or not. 
These findings are reported in detail in Effectiveness of homeopathy for any clinical 
condition: evaluation of the evidence. Overview report.(1) 
 
NHMRC DRAFT INFORMATION PAPER [APRIL 2014] 
Draft for public consultation  14 
Table 1. Summary of evidence from studies of homeopathy 
Conclusions Why NHMRC reached this conclusion 
Homeopathy is not more effective than placebo for the treatment of these health conditions: 
 adenoid vegetation in children (abnormal growth of adenoid tonsils behind the nose) 
 asthma 
 anxiety or stress-related conditions 
 diarrhoea in children – combined homeopathy tablet (clinical homeopathy) 
 headache and migraine 
 muscle soreness (delayed onset) 
 labour (inducing or shortening labour) 
 pain due to dental work  
 pain due to orthopaedic surgery 
 postoperative ileus (abnormally slow movement of bowel after surgery)  
 premenstrual syndrome 
 upper respiratory tract infections (e.g. colds) 
 warts. 
For each condition, homeopathy was reported to be not 
more effective than placebo in either: 
 all the studies found (regardless of size and quality), 
or  
 a large majority of those studies that were reliable 
(good-quality, well designed and with enough 
participants for a meaningful result). 
There is no reliable evidence that homeopathy is more effective than placebo for the treatment of these health 
conditions: 
 allergic rhinitis 
 attention deficit/hyperactivity disorder (ADHD) in children 
 bruising 
 chronic fatigue syndrome  
 diarrhoea in children – individualised homeopathy 
 fibromyalgia 
 hot flushes in women who have had breast cancer  
 human immunodeficiency virus (HIV) infection 
 influenza-like illness 
 rheumatoid arthritis 
 sinusitis 
 sleep disturbances or circadian rhythm disturbances 
 stomatitis (inflammation of the mouth) due to chemotherapy 
 ulcers. 
For each condition, although some studies reported that 
homeopathy was more effective than placebo, these 
studies were not reliable. They were not good quality 
(well designed and well done), or they had too few 
participants to give a meaningful result, or both. 
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There is no reliable evidence that homeopathy is as effective as the other therapies for the treatment of these health 
conditions: 
 acute otitis media or otitis media with effusion (inflammation of the middle ear) in children (compared with 
antibiotics, mucolytic medicines, secretolytic medicines, antipyretic medicines, nasal sprays, or monitoring 
the condition but not providing treatment [‘watchful waiting’]) 
 allergic rhinitis (compared with antihistamines, cortisone or intranasal cromolyn sodium) 
 anxiety or stress-related conditions (compared with lorazepam, diazepam or cognitive behavioural therapy) 
 depression (compared with fluoxetine or diazepam) 
 eczema (compared with corticosteroids, antihistamines, or other unspecified therapies) 
 non-allergic rhinitis (compared with aspirin, xylometazoline or other therapies) 
 osteoarthritis (compared with paracetamol or various nonsteroidal anti-inflammatory drugs) 
 upper respiratory tract infection (compared with anti-inflammatory drugs, antibiotics or other therapies). 
For each condition, although some studies reported that 
homeopathy was as effective as or more effective than 
another treatment, these studies were not reliable. They 
were not good quality (well designed and well done), or 
they had too few participants to give a meaningful result, 
or both. 
There is no reliable evidence on which to draw a conclusion about the effectiveness of homeopathy, compared with 
placebo, for the treatment of these health conditions: 
 acne vulgaris  
 acute otitis media (inflammation of the middle ear) in children 
 acute ankle sprain 
 acute trauma 
 amoebiasis and giardiasis (gastrointestinal conditions caused by parasites) 
 ankylosing spondylitis  
 boils and pyoderma (types of skin infections) 
 Broca’s aphasia in people who have had a stroke  
 bronchitis 
 cholera 
 cough 
 chronic polyarthritis 
 dystocia (difficult labour) 
 eczema 
 heroin addiction 
 knee joint haematoma (bruising) 
 lower back pain 
 nausea and vomiting associated with chemotherapy 
 oral lichen planus 
 osteoarthritis 
 proctocolitis 
For each condition, only one study that compared 
homeopathy with placebo was found, and this study was 
unreliable. It was either poor quality (poorly designed or 
poorly done) or unknown quality, or it had too few 
participants to give a meaningful result, or both. 
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 postoperative pain-agitation syndrome 
 radiodermatitis (skin damage caused by radiotherapy) in women with breast cancer 
 seborrhoeic dermatitis 
 suppression of lactation after childbirth in women who elect not to breastfeed 
 stroke 
 traumatic brain injury (mild) 
 uraemic pruritis 
 vein problems due to cannulas in people receiving chemotherapy. 
There is no reliable evidence on which to draw a conclusion about the effectiveness of homeopathy compared with 
other therapies for the treatment of these health conditions: 
 burns (second- and third-degree) 
 fibromyalgia 
 irritable bowel syndrome 
 malaria 
 proctocolitis (inflammation of the rectum and colon) 
 recurrent vulvovaginal candidiasis (yeast infection of the vagina and/or vulva, also called ‘thrush’) 
 rheumatoid arthritis. 
For each condition, only one study that compared 
homeopathy with another treatment was found, and this 
study was unreliable. It was either poor quality (poorly 
designed or poorly done) or unknown quality, or it had 
too few participants to give a meaningful result, or both. 
Notes: 
Systematic reviews included in the overview searched for, but did not find, studies assessing homeopathy in people with these conditions: borderline personality disorder, 
dementia, constipation in children, glaucoma, nocturnal enuresis (bedwetting), lower urinary tract symptoms in men, and chronic facial pain. 
Systematic reviews included in the overview searched for, but did not find, studies that compared homeopathy with placebo in people with these conditions: burns (second 
and third degree), depression, irritable bowel syndrome, lower back pain, malaria, non-allergic rhinitis, and vulvovaginal candidiasis. For these conditions, systematic reviews 
found only studies that compared homeopathy with other treatments. 
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Information provided by homeopathy interest groups and 
individuals 
In addition to commissioning an overview of systematic reviews,(1) NHMRC assessed 
evidence provided by homeopathy interest groups and the public. The findings from these 
submissions are summarised the report Effectiveness of homeopathy for any clinical 
condition: evaluation of the evidence. Review of submitted literature.(2)  
The submissions included published research studies on three more health conditions that 
were not included the systematic reviews:(2)  
 pain after total abdominal hysterectomy 
 tracheal secretions in critically ill patients with a history of tobacco use and chronic 
obstructive pulmonary disease 
 wound healing after foot surgery. 
These studies were of poor quality. Problems included poor design, poor reporting of the 
study design or method, or too few participants.(2) 
The results of these studies did not alter NHMRC’s overall conclusions about the 
effectiveness of homeopathy because of their poor quality, and because they were only 
selected examples of studies on those conditions. To reach a conclusion about whether 
homeopathy was effective for treating those conditions, it would be necessary to search for 
all available homeopathy studies on each condition and assess them as a single body of 
evidence in a systematic review. 
Evidence-based guidelines and government reports 
A number of evidence-based clinical practice guidelines published or funded by the UK 
National Institute for Health and Clinical Excellence recommend against the use of 
homeopathy for treating various health conditions, due to lack of evidence for its 
effectiveness.(9-14) 
A report by the UK House of Commons Science and Technology Committee stated that ‘the 
systematic reviews and meta-analyses conclusively demonstrate that homeopathic products 
perform no better than placebos’.(6) This report concluded that any health benefits that 
people experience when they use homeopathy is solely due to the placebo effect.(6) In 
contrast, a Swiss Health Technology Assessment report on Homeopathy commissioned by 
the Swiss government concluded that homeopathy is a ‘valuable addition to the conventional 
medical landscape’.(7) The difference between the findings of the UK and Swiss reports was 
mainly due to their different methods for assessing research evidence. 
Both the UK and Swiss reports have been criticised by those who disagree with their methods 
and findings. The UK report was criticised by the British Homeopathic Association, which 
argued that the House of Commons Science and Technology Committee failed to take into 
account certain systematic reviews and meta-analyses, and omitted or misrepresented 
evidence in favour of homeopathy.(15) The Swiss report was criticised by a review that 
argued it was ‘scientifically, logically and ethically flawed’, ‘misinterprets studies previously 
exposed as weak’ and ‘attempts to discredit randomised controlled trials as the gold standard 
of evidence’.(16) 
In assessing the evidence, NHMRC considered these reports and their methodologies.  
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Limitations of the assessment and evidence base for homeopathy 
The studies of homeopathy were generally poor quality. For some health conditions, this 
meant that no conclusion could be made on whether or not homeopathy was effective. For 
other conditions, this meant that NHMRC could not be confident that the results reported by 
studies were reliable.  
NHMRC’s overview was based on finding systematic reviews of homeopathy, rather than 
searching for all individual published studies of homeopathy. The advantage of this strategy 
was to make use of the large amount of work that had already been done by researchers 
around the world in finding and assessing studies. However, there were also some 
disadvantages: 
 As the overview only included systematic reviews, some individual studies of 
homeopathy may not have been considered (particularly recent studies published since 
the latest systematic reviews). NHMRC offset this risk by also considering evidence 
provided by homeopathy interest groups and the public, which included some extra 
studies,(2) and by inviting public consultation. 
 To assess the quality of individual studies, the research group had to rely on the way that 
these were reported by systematic reviews. Details of study design (e.g. the outcomes 
measured and the length of follow up), the statistical significance of the results, and the 
clinical importance of any reported health benefits, were not always available. Also, the 
description of an individual study was sometimes inconsistent between systematic 
reviews.  
 The systematic reviews varied in quality. Poor reporting and flawed methodology in 
individual studies was sometimes exacerbated by incomplete reporting in the systematic 
reviews. 
 It was not possible to separate the evidence for clinical homeopathy and individualised 
homeopathy, because most of the systematic reviews did not analyse these separately. 
 It was not possible to make conclusions about the effects of homeopathy on each of the 
specific health outcomes (e.g. pain, mobility) relevant to a particular health condition 
(e.g. arthritis), because of the large number of outcomes and the different reporting of 
outcomes between the different systematic reviews. Instead, outcomes were aggregated 
for each health condition and a single conclusion was made. 
 It was often difficult to find the details of other treatments with which homeopathy was 
compared in research studies. To interpret the studies that compared homeopathy with 
another treatment, it is necessary to understand whether the other treatment was an 
effective standard treatment. This information was often not available from the systematic 
reviews. 
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NHMRC’s interpretation of the assessment of the evidence 
on the effectiveness of homeopathy 
In line with NHMRC’s function to “advising the community” under section 7(1)(a) of the 
National Health and Medical Research Council Act 1992 (the Act) and based on the 
assessment of the evidence of effectiveness of homeopathy NHMRC believes: 
 There is no reliable evidence that homeopathy is effective for treating health 
conditions. 
 People who choose homeopathy instead of proven conventional treatment may put 
their health at risk if safe and evidence based treatments are rejected or delayed in 
favour of homeopathic treatment. 
 Homeopathy should not be used to treat health conditions that are serious, or could 
become serious. 
 People who are considering whether to use homeopathy should first get advice from a 
health professional (e.g. GP, specialist, nurse practitioner or pharmacist). Those who 
use homeopathy should tell their health professionals, and should keep taking any 
conventional medicines that they have been prescribed. 
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Definition of special terms 
Body of evidence The set of collected research evidence on a 
specified research question 
Complementary and alternative medicine The range of health care practices, therapies, 
procedures and devices that are not currently 
considered to be part of conventional medicine 
Controlled trial (controlled study) A research study in which the treatment being 
evaluated was compared with either another 
treatment, or placebo (a treatment or substance 
known to have no health benefits), in similar 
groups of people with the health condition 
Effectiveness (of a treatment for a health condition) 
 The extent to which a treatment works or not 
when used to treat health conditions in patients 
Evidence (medical evidence or clinical evidence) 
 Published findings of health research in humans 
using internationally accepted methods (e.g. 
studies that have been properly designed to 
assess whether or not a treatment is effective). It 
does not include individual experiences, 
testimonials or case reports, or research that was 
not done using standard methods. 
Health condition (also clinical condition) Any medical condition or health problem that 
causes a person to have symptoms or causes 
physical changes that can be recognised by a 
health professional. Health conditions include 
side effects of treatments such as medicines or 
surgery.  
Homeopathy A type of complementary and alternative 
medicine (See What is homeopathy? [page 5]) 
Placebo (in research studies) A sham treatment that is compared with the 
treatment being tested 
Placebo effect An effect people experience when they believe 
that a treatment is effective, even if the treatment 
is a sham (e.g. an empty pill capsule or coloured 
water used in a research study) 
Prospective trial (prospective study) A research study that measures effects as they 
occur over time, beginning from an agreed time 
point (not by using records made in the past). 
The health outcomes to be measured are defined 
in advance, the way to measure the effects of 
treatment on these outcomes is planned in 
advance, and the results are then measured at 
specified times. 
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Randomised controlled trial A research study conducted in a standardised 
way to test whether a treatment is effective or 
not, by comparing it with another treatment or 
with placebo. This involves randomly allocating 
participants to receive the treatment or not, and 
measuring the effects on their health using pre-
defined measurements. 
Study (research study) A planned, structured scientific research project 
designed to see whether a treatment is effective 
in humans (e.g. a trial) 
Systematic review  A type of research that involves searching for all 
the published evidence (e.g. research studies) to 
answer a particular question, such as whether a 
particular treatment is more effective than no 
treatment or as effective as another treatment for 
treating a specified health condition in a certain 
group of  patients (e.g. children, adults). There 
are internationally accepted standards for 
good-quality systematic reviews. 
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The Homeopathy Working Committee 
The Homeopathy Working Committee was made up of experts in evidence-based medicine, 
clinical trials, and complementary medicines research. The Committee’s roles were:‡‡‡ 
 to guide an independent review of the evidence on the effectiveness of homeopathy. This 
included providing advice on methods of evaluating and interpreting relevant 
information. 
 to guide NHMRC to produce a document that summarises current evidence on whether 
homeopathy is effective for health conditions, and give Australians information to help 
them make decisions about using homeopathy as part of their health care. 
Homeopathy Working Committee members are listed in Table 2.
§§§
 
Table 2. The Homeopathy Working Committee 
Name and qualifications Job title and other relevant roles 
Chair 
Professor Paul Glasziou, MBBS, 
PhD, FRACGP  
General practitioner 
Professor and Director of the Centre for Research into 
Evidence-Based Practice, Bond University, Queensland 
Expert in evidence-based medicine 
Professor Peter Brooks, AM, 
MBBS, MD (Lund), FRACP, 
FAFRM, FAFPHM, 
MDHonCausa, FRCP (Glas, 
Edin) 
Rheumatologist 
Director of the Australian Health Workforce Institute, University of 
Melbourne, Victoria (To September 2013) 
Executive Director Research, Northern Hospital, Epping, Victoria 
Former board member, Australian Centre for Complementary 
Medicine Education and Research, University of Queensland 
Professor Frederick Mendelsohn, 
AO, MB BS, PhD, MD, FRACP 
Neuroscientist 
Former Chair in Medicine and Director of the Howard Florey 
Institute, University of Melbourne, Victoria 
Mr John Stubbs, BA, DipAcct Consumer 
Executive Officer, canSpeak 
Honorary Associate, School of Medicine, University of Sydney, 
New South Wales 
Member, Australian Health Ethics Committee, NHMRC 
Member, Consumer Consultative Group, NHMRC 
Dr Evelin Tiralongo, 
BPharm(Hons), PhD, 
GradCertHigherEd 
Pharmacist 
Senior lecturer and researcher, School of Pharmacy and Griffith 
                                                 
‡‡‡
 The Homeopathy Working Committee’s full terms of reference are listed at NHMRC’s Complementary and 
alternative medicines web page (http://www.nhmrc.gov.au/your-health/complementary-and-alternative-
medicines). 
§§§
 Information about individual committee members’ credentials and conflicts of interest is available on the 
NHMRC website (http://www.nhmrc.gov.au/your-health/complementary-and-alternative-medicines). 
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Health Institute, Griffith University, Gold Coast, Queensland 
Member, Clinical Trials Coordinating Centre, Griffith University 
Member, Society for Medicinal Plant and Natural Product 
Research 
Dr Nikolajs Zeps, BSc(Hons), 
PhD 
Research scientist 
Director, St John of God Subiaco Hospital Research network 
Adjunct Associate Professor, School of Surgery and School of 
Pathology and Laboratory Medicine, University of Western 
Australia  
Adjunct Associate Professor, Faculty of Medicine, University of 
Notre Dame, Western Australia 
Member, Research Committee, NHMRC 
Professor Chris Baggoley, AO, 
BVSc(Hons), MBBS, BSocAdmin, 
FACEM, FIFEM 
Member May 2012–March 2013 
Observer March–June 2013 
Australian Government Chief Medical Officer 
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